Orbimed Advisors - SINOVAC BIOTECH LTD ownership

SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 30 filers reported holding SINOVAC BIOTECH LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 3.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of SINOVAC BIOTECH LTD
ValueSharesWeighting
Q3 2023$340,000,0000.0%2,718,7350.0%7.22%
+17.2%
Q2 2023$340,000,0000.0%2,718,7350.0%6.16%
-7.7%
Q1 2023$340,000,0000.0%2,718,7350.0%6.67%
+2.6%
Q4 2022$340,000,000
-0.1%
2,718,7350.0%6.50%
+2.9%
Q3 2022$340,500,000
-2.6%
2,718,7350.0%6.32%
-0.2%
Q2 2022$349,500,000
+380.7%
2,718,735
-4.3%
6.33%
+577.3%
Q4 2021$72,700,000
-7.3%
2,839,5000.0%0.94%
+8.5%
Q3 2021$78,400,000
+2.1%
2,839,5000.0%0.86%
+10.9%
Q2 2021$76,800,000
+6.7%
2,839,5000.0%0.78%
+15.5%
Q1 2021$72,000,0000.0%2,839,5000.0%0.67%
+6.8%
Q4 2020$72,000,000
+163.7%
2,839,5000.0%0.63%
+83.7%
Q3 2020$27,300,000
+7.1%
2,839,5000.0%0.34%
-4.5%
Q2 2020$25,500,000
+48.7%
2,839,5000.0%0.36%
+24.7%
Q1 2020$17,151,0000.0%2,839,5000.0%0.29%
+17.6%
Q4 2019$17,151,000
+3.3%
2,839,5000.0%0.24%
-22.2%
Q3 2019$16,611,0000.0%2,839,5000.0%0.32%
+22.6%
Q2 2019$16,611,000
-9.6%
2,839,5000.0%0.26%
-9.5%
Q1 2019$18,372,000
-6.8%
2,839,5000.0%0.28%
-22.0%
Q4 2018$19,706,000
-8.9%
2,839,5000.0%0.36%
+39.5%
Q3 2018$21,637,000
+2.1%
2,839,5000.0%0.26%
+3.2%
Q2 2018$21,183,000
-13.4%
2,839,5000.0%0.25%
-16.5%
Q1 2018$24,448,000
+9.3%
2,839,5000.0%0.30%
+7.1%
Q4 2017$22,375,000
+19.0%
2,839,500
+6.4%
0.28%
+57.2%
Q3 2017$18,806,000
+4.4%
2,667,5000.0%0.18%
-4.8%
Q2 2017$18,006,000
+17.8%
2,667,5000.0%0.19%
+9.2%
Q1 2017$15,285,000
-2.9%
2,667,5000.0%0.17%
-13.9%
Q4 2016$15,738,0000.0%2,667,5000.0%0.20%
+12.3%
Q3 2016$15,738,000
-0.5%
2,667,5000.0%0.18%
+8.5%
Q2 2016$15,818,000
-7.2%
2,667,5000.0%0.16%
-7.8%
Q1 2016$17,045,000
+11.7%
2,667,5000.0%0.18%
+29.7%
Q4 2015$15,258,000
+12.6%
2,667,5000.0%0.14%
+0.7%
Q3 2015$13,551,000
-3.2%
2,667,5000.0%0.14%
+33.0%
Q2 2015$14,004,000
+5.8%
2,667,5000.0%0.10%
-8.8%
Q1 2015$13,231,000
-10.3%
2,667,500
-5.5%
0.11%
-19.9%
Q4 2014$14,756,000
+8.7%
2,821,5000.0%0.14%
-0.7%
Q3 2014$13,571,000
+46.9%
2,821,500
+72.3%
0.14%
+31.5%
Q2 2014$9,236,000
-21.7%
1,637,5000.0%0.11%
-25.5%
Q1 2014$11,790,000
+17.6%
1,637,5000.0%0.14%
-1.4%
Q4 2013$10,022,000
-11.1%
1,637,500
-13.1%
0.15%
-26.9%
Q3 2013$11,268,000
+52.2%
1,884,2000.0%0.20%
+28.0%
Q2 2013$7,405,0001,884,2000.16%
Other shareholders
SINOVAC BIOTECH LTD shareholders Q1 2021
NameSharesValueWeighting ↓
SAIF Advisors Ltd 10,780,820$405,359,00085.85%
Vivo Capital, LLC 5,900,000$38,173,0001.34%
Orbimed Advisors 2,839,500$72,000,0000.67%
Yorktown Management & Research Co Inc 74,893$485,0000.40%
Neumann Advisory Hong Kong Ltd 315,586$2,0420.36%
Financial Gravity Asset Management, Inc. 123$798,0000.02%
Freedom Investment Management, Inc. 34,898$117,0000.01%
Skandinaviska Enskilda Banken AB (publ) 40,000$259,0000.00%
Renaissance Technologies 2,375,841$1,537,0000.00%
WELLS FARGO & COMPANY/MN 1,922$00.00%
View complete list of SINOVAC BIOTECH LTD shareholders